• Background
logo
  • Home
  • Who we are
    Who we are
    • Overview
    • Fact Sheet
    • Chairman's Profile
    • Board of Directors
    • Team Wockhardt
    Faclities
    • Manufacturing
    • Contract Manufacturing
    • Virtual Tour
    Global Presence
    • Our Footprints
    • Other websites
    Community Care
    • Wockhardt Foundation
    • Wockhardt HIV/AIDS Care
  • How we touch lives
    R & D
    • Overview
    • Generics
    • New Drug Discovery
    Biotechnology
    • Overview
    • Biopharmaceuticals
    • Biotechnology Park
    • Gallery
    Corporate Regulatory
    • Marketing & Regulatory Infrastructure
  • Investor Connect
    • Financials at a glance
    • Annual Reports
    • Quarterly Reports
    • Shareholding Pattern
    • Chairman's letter to Shareowners
    • Chairman's AGM Speech
    • Code of Conduct
    • Financial Press Releases
    • Stock Quotes
    • Investor Contact
  • Partnerships
    • Collaborations / Partnerships
  • Media
    • Press Releases
    • Media Kit
    • Videos
    • Media Contact
  • People
    • Life at Wockhardt
    • Frequently Asked Questions
    • Focus on Development
    • Meet our People
    • Career Openings
  • Get in touch
    • Corporate Office
    • International Offices
    • Research Centres
    • Manufacturing Plants
  • Home
  • >
  • Media
  • >
  • Press Releases

Press Releases

Press releases
Press Releases Archives
123Prev
Wockhardt launches generic version of Rhinitis drug Flonase® nasal spray
10 January, 2012
Wockhardt to divest its Nutrition business to Danone
02 August, 2011
Wockhardt receives tentative US FDA approval for generic version of depression drug Cymbalta®
08 July, 2011
Wockhardt receives tentative US FDA approval for generic version of Patanol® ophthalmic solution
01 July, 2011
Wockhardt launches three new products in three weeks, in the United States
21 June, 2011
Wockhardt receives US FDA approval for generic version of Aricept® tablets
25 April, 2011
Wockhardt receives US FDA approval for generic version of Effexor XR® capsules
19 April, 2011
Wockhardt and Sheffield Bio-Science, USA announce a strategic alliance to distribute recombinant insulin in cell culture markets globally
21 February, 2011
Wockhardt launches generic version of Protonix® tablets in the US
21 January, 2011
Wockhardt receives US FDA approval for the generic version of Allegra-D® 12 hour
20 October, 2010
123Prev
© 2012 wockhardt. All rights reserved.Sitemap | Terms & conditions | Disclaimer | XHTML1.0 | CSS
WOCK-STOCK Stock WatchMarket Tracker